Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial

Gynuity Health Projects

Status: Completed

Conditions: Abortion, Induced

Treatments: Drug: placebo; Drug: mifepristone+misoprostol; Drug: misoprostol

Study type: Interventional

Funder types: Other

Identifiers

NCT00784186

1.3.1

Details and patient eligibility

About

The primary goal of this study is to determine the clinical advantage of pre-treatment with mifepristone in second trimester misoprostol induction abortion. This will be a randomized controlled double-blinded trial of 260 women comparing misoprostol alone to mifepristone plus misoprostol for second trimester (14-21 weeks' LMP) medical abortion.

Enrollment: 120 patients

Sex: Female

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 14 to 21 weeks gestation, based on menstrual history and clinical exam (with or without ultrasound)
• Meet legal criteria to obtain abortion
• Present with closed cervical os and no vaginal bleeding
• Live fetus at time of presentation for service
• Have no contraindications to study procedures, according to provider
• Be able to consent to procedure, either by reading consent document or by having consent document read to her
• Be willing to follow study procedures

Exclusion criteria

• Known previous transmural uterine incision
• Known allergy to mifepristone or misoprostol/prostaglandin or other contraindications to the use of mifepristone or misoprostol
• Any contraindications to vaginal delivery, including placenta previa
• Presentation in active labor (defined as moderate to severe contractions every 10 minutes or less)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

120 participants in 2 patient groups

mifepristone+misoprostol

Experimental group

Description:

200 mg mifepristone followed by 800 mcg buccal misoprostol repeated every 3 hours until complete abortion or maximum of 5 doses.

Treatment:

Drug: mifepristone+misoprostol

Drug: misoprostol

misoprostol

Experimental group

Description:

800 mcg buccal misoprostol repeated every 3 hours until complete abortion or maximum of 5 doses.

Treatment:

Drug: placebo

Drug: misoprostol